Recent ELEV News
- Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements • PR Newswire (US) • 05/02/2024 11:30:00 AM
- Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024 • PR Newswire (US) • 04/08/2024 08:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/06/2024 01:14:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 12:45:37 PM
- Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements • PR Newswire (US) • 03/06/2024 12:30:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/06/2024 12:00:50 PM
- Elevation Oncology to Present Preclinical Proof-of-Concept Data for HER3-ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024 • PR Newswire (US) • 03/05/2024 09:50:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:40:32 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:21:36 PM
- Elevation Oncology Appoints Experienced Clinical Development Leaders Julie Cherrington, Ph.D. and Alan Sandler, M.D. to Board of Directors • PR Newswire (US) • 03/04/2024 12:30:00 PM
- Elevation Oncology to Participate in Upcoming Investor Conferences • PR Newswire (US) • 02/28/2024 12:30:00 PM
- Elevation Oncology Expands Ongoing Phase 1 Clinical Trial of EO-3021 Globally, Dosing First Patient in Japan • PR Newswire (US) • 02/22/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 10:02:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:57:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:52:31 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:45:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 09:15:16 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/22/2024 09:57:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/22/2024 09:35:20 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/22/2024 09:24:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 12:45:11 PM
- Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors • PR Newswire (US) • 01/22/2024 12:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/09/2024 09:24:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 12:40:10 PM
- Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones • PR Newswire (US) • 01/05/2024 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM